Abstract
Objective
To evaluate the efficacy and safety of sublingual methylcobalamin for the treatment of vitamin B12 deficiency anemia in children.
Methods
A single arm intervention study was conducted between November, 2020 and April, 2022 in children aged 1–12 years with vitamin B12 deficiency anemia. Children aged 1–6 years received a tablet of methylcobalamin (1500 mcg) by sublingual route every alternate day (three doses) while those aged 7–12 years received five such doses. Thereafter, one such sublingual tablet was given weekly and all participants were followed-up for 6 weeks.
Results
37 children with a mean (SD) age of 8.2 (4.1) years were treated and followed-up. On day 10, no child needed rescue therapy with parenteral methylcobalamin. After 6 weeks, the mean (SD) serum cobalamin increased from 123.3 (35.5) pg/mL to 507.3 (274.2) pg/mL (P<0.001), plasma homocysteine decreased from 48.9 (17.8) µmol/L to 16.3 (8.5) µmol/L (P<0.001), the mean (SD) hemoglobin increased by 2.3 (1.1) g/dL (P<0.001), and MCV decreased by 12.9 (6.8) fL (P<0.001). 67.6% children persisted to have anemia, albeit majority of them had mild or moderate anemia. There were no unsolicited side-effects reported.
Conclusion
Sublingual methylcobalamin is effective for the treatment of vitamin B12 deficiency anemia in children; although, the duration of treatment needs to be longer than six weeks.
References
International Institute for Population Sciences, ICF International. National Family Health Survey (NFHS-4), 2015–16. International Institute for Population Sciences, 2017.
Devalia V, Hamilton MS, Molloy AM, the British Committee for Standards in Haematology. Guidelines for the Diagnosis and Treatment of Cobalamin and Folate Disorders. Br J Haematol. 2014;166:496–513.
Wang H, Li L, Qin LL, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655.
Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008;112:2214–21.
Tuöba-Kartal A, Çađla-Mutlu Z. Comparison of sublingual and intramuscular administration of vitamin b12 for the treatment of vitamin b12 deficiency in children. Rev Invest Clin. 2020;72:380–85.
Orhan Kiliç B, Kiliç S, lahin Erođlu E, et al. Sublingual methylcobalamin treatment is as effective as intramuscular and peroral cyanocobalamin in children age 0–3 years. Hematology. 2021;26:1013–7.
Varkal MA, Karabocuoglu M. Efficiency of the sublingual route in treating B12 deficiency in infants. Int J Vitam Nutr Res. 2021 Aug 25. Epub ahead of print.
Kotilea K, Quennery S, Decroës V, Hermans DA. Successful sublingual cobalamin treatment in a child with short-bowel syndrome. J Pediatr Pharmacol Ther. 2014;19:60–3.
Bensky MJ, Ayalon-Dangur I, Ayalon-Dangur R, et al, Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency. Drug Deliv Transl Res. 2019;9:625–30.
World Health Organization. Nutritional anaemias: Tools for effective prevention and control. World Health Organization, 2017. Accessed March 23, 2023. Available from: http://apps.who.int/iris/bitstream/10665/259425/1/9789241513067-eng.pdf?ua=1
Pluncevic Gligoroska J, Gontarev S, Dejanova B, et al. Red blood cell variables in children and adolescents regarding the age and sex. Iran J Public Health. 2019;48:704–12.
Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009;60:39–54.
Verma D, Chandra J, Kumar P, et al. Efficacy of oral methylcobalamin in treatment of vitamin B12 deficiency anemia in children. Pediatr Blood Cancer. 2017;64:e26698.
Bor MV, Cetin M, Aytaç S, et al. Long term biweekly 1 mg oral vitamin B12 ensures normal hematological parameters, but does not correct all other markers of vitamin B12 deficiency; a study in patients with inherited vitamin B12 deficiency. Haematologica. 2008;93:1755–8.
VanderBrink BA, Cain MP, King S, et al. Is oral vitamin B 12 therapy effective for vitamin B12 deficiency in patients with prior ileocystoplasty? J Urol. 2010;184:1781–5.
Altay C, Cetin M. Oral treatment in selective vitamin B12 malabsorption. J Pediatr Hematol Oncol. 1997;19:245–6.
Sezer RG, Bozaykut A, Akođlu HA, Özdemir GN. The efficacy of oral vitamin B12 replacement for nutritional vitamin B12 deficiency. J Pediatr Hematol Oncol. 2018;40: e69–e72.
Berlin H, Berlin R, Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand. 1968;184:247–58.
Funding
Funding: Intramural Research Grant
Author information
Authors and Affiliations
Contributions
Contributors: CS: data collection, data analysis and draft preparation; SK: data analysis, draft preparation and revised the manuscript; PD: conceptualized the research, supervised the work, analyzed the data and gave critical inputs; SG: supervision of work, data analysis and critical inputs; RA, SS: laboratory work, data analysis and critical inputs; NR, MM: data collection, analysis and critical inputs. All authors approved final manuscript and are accountable.
Corresponding author
Ethics declarations
Ethics clearance: Institutional Ethics Committee for Human Research, UCMS; No. IEC-HR/2020/PG/46/64-R1; IEC-HR/2021/51/6. IEC. Post Graduate Institute of Child Health, Noida; No. 2021-03-IM-14 datedAug 14, 2021.
Competing interests: None stated.
Rights and permissions
About this article
Cite this article
Saxena, C., Kumari, S., Dewan, P. et al. Therapeutic Response to Sublingual Methylcobalamin in Children With Vitamin B12 Deficiency Anemia. Indian Pediatr 60, 913–916 (2023). https://doi.org/10.1007/s13312-023-3035-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-023-3035-6